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Abstract 
The t(5;14)(q35;q32) chromosomal translocation is specifically
 
observed in up to 20% of 
childhood T-cell acute lymphoblastic
 
leukemia (T-ALL). It affects the BCL11B/CTIP2 locus 
on chromosome
 
14 and the RANBP17-TLX3/HOX11L2 region on chromosome 5. It leads
 
to 
ectopic activation of TLX3/HOX11L2. To investigate the reasons
 
of the association between 
t(5;14) and T-ALL, we isolated the
 
translocation breakpoints in 8 t(5;14) patients. Sequence 
analyses
 
did not involve recombinase activity in the genesis of the translocation.
 
We used 
DNAse1 hypersensitive experiments to locate transcriptional
 
regulatory elements downstream 
of BCL11B. By transient transfection
 
experiments, 2 of the 6 regions demonstrated cis-
activation
 
properties in T cells and were also effective on the TLX3 promoter.
 
Our data 
indicate that the basis of the specific association
 
between t(5;14) and T-ALL lies on the 
juxtaposition of TLX3
 
to long-range cis-activating regions active during T-cell differentiation. 
 
Introduction 
 Maturation of immunoglobulin (Ig) and T-cell receptor (TCR)
 
genes is associated with 
somatic V(D)J recombinase rearrangements
 
occurring during lymphoid development.
1
 A 
protein complex containing
 
both ubiquitously expressed and lymphoid-specific proteins 
(RAG1,
 
RAG2, and TdT) catalyzes this process. The complex interacts
 
with recombination 
sequences (RSs) that limit the segments to
 
be rearranged. During the recombination process, 
the extremities
 
are nibbled, and additional nucleotides (Ns) are added without
 
template by the 
TdT.
1
 During this process, which includes double-strand
 
DNA break, the Ig and TCR genes 
are prone to illegitimate rearrangements
 
and chromosomal translocations observed in human 
T-cell acute
 
lymphoblastic leukemia (T-ALL) often involve the site of the
 
TCR genes.
2
 
Molecular analyses of the chromosomal breakpoints
 
of these translocations often showed 
hallmark of recombinase
 
activity and allowed the characterization of numerous T-ALL
 
oncogenes.
 
 
 Many of the oncogenic events specific for T-cell leukemogenesis
 
result in the 
activation of transcription factors, such as HOX11/TLX1,
 
LMO2, or TAL1/SCL.
3,4
 A frequent 
event in T-ALL is the occurrence
 
of a 90-kb deletion of chromosome 1 sequences, 
juxtaposing the
 
first exon of the SIL gene, to the 5' part of the TAL1 gene.
5 
This rearrangement 
is observed in up to 20% of childhood T-ALL
 
samples, and not in other ALL subtypes. The 
fusion points of
 
the deletion bear the hallmarks of recombinase activity, which
 
is therefore 
thought to be responsible for this rearrangement
 
and provides the grounds for its specific 
association with T-ALL.
 
Illegitimate recombinase activity is also responsible for at
 
least some 
of the deletion affecting the P16-ARF tumor-suppressor
 
locus observed in a T-ALL.
6 
 
 Ectopic expression of the homeobox transcription factor TLX3
 
was recently reported in 
childhood T-ALL, virtually always in
 
association with genomic rearrangement of its locus.
7-10
 
It
 
is mainly associated with a cryptic t(5;14)(q35;q32) chromosomal
 
translocation that 
recombines the RANBP17-TLX3 and BCL11B loci.
11,12 
To uncover the mechanisms 
responsible for the translocation
 
and ectopic expression of TLX3, and the reason for the 
specific
 
association between t(5;14) and T-ALL, we analyzed the nucleotide
 
sequence at the 
breakpoint of 8 examples of t(5;14). In addition,
 
we identified cis-transcriptional regulatory 
elements lying
 
downstream of BCL11B, which could be involved in the up-regulation
 
of TLX3 
following the translocation.
 
 
Materials and Methods 
 Samples were obtained with informed consent, in accordance with
 
the Declaration of 
Helsinki. Approval for this study was given
 
by the INSERM review board. The hematologic 
and immunophenotypic
 
characteristics and conventional karyotypes of the 8 T-ALL patients
 
with t(5;14)(q35;q32) are listed in Table S1, available on the
 
Blood website (see the 
Supplemental Materials link at the top
 
of the online article). The procedure for DNAse1 
experiments
 
is described in Figure S2. DNA analyses were performed using
 
standard 
techniques. DND41, HPB-ALL, and Jurkat are T-ALL–derived
 
cell lines; DND41 and HPB-
ALL bear variant t(5;14).
12,13
 The
 
primers used are listed in Table S2. Inverse polymerase 
chain
 
reaction (PCR) was performed as described previously,
12
 and
 
classical PCR was then 
used to confirm breakpoint location and
 
sequence. Sequence analyses were performed locally 
or at http://genome.ucsc.edu
 
or http://www.ncbi.nlm.nih.gov.gate1.inist.fr. Appropriate 
fragments were cloned
 
in pGL3 backbone (Promega, Madison, WI). Cells (2.5 x 10
5
) were
 
transfected with 0.5 to 2 µg reporter gene constructs
 
using Lipofectine (Invitrogen, Frederick, 
MD), and the luciferase
 
activity was determined using luciferase assay system (Promega)
 
after 
24 hours. A representative experiment is shown, but every
 
experiment was repeated at least 3 
times in duplicate. The results
 
were similar with or without normalization (using a thymidine 
kinase promoter–driven -galactosidase reporter). 
 
 
Results and Discussion 
 
Cloning of the chromosomal translocation breakpoints  
 Approximate mapping of the breakpoints was done by fluorescence
 
in situ 
hybridization (FISH), analyses and more precise localization
 
was achieved by Southern 
blotting analysis using single-copy
 
probes (data not shown and Figure 1A). The translocation 
breakpoints
 
were amplified from patient's genomic DNA using an inverse PCR
 
approach and 
analyzed by direct sequencing. Both translocation
 
breakpoints (der5 and der14) could be 
analyzed in 7 cases and
 
the fusion points exhibited complex features in only patient
 
1 (Figure 
S1). Most of the fusion points exhibited N nucleotides.
 
In patients 3 and 7, no N nucleotides 
were observed, suggesting
 
that the translocation could have occurred in a cell that did
 
not 
express the TdT. Of importance, no convincing RS-like sequences
 
were observed at the 
translocation breakpoints, suggesting that
 
the recombinase activity is not involved in the 
occurrence of
 
the translocation. 
 
 
DNAse1 hypersensitive site (HSS) mapping  
 It has been proposed that the transcriptional activation of
 
TLX3 could result from cis-
activation of the gene by a BCL11B
 
transcriptional regulatory element, juxtaposed to TLX3 
following
 
the translocation.
12,15
 Within the hematopoietic system, expression
 
of the BCL11B 
gene is restricted to the T-cell differentiation
 
pathway.
7,16
 It encodes a transcription factor 
essential to
 
thymocyte differentiation.
17
 The location of the translocation
 
breakpoints in 
patients 1 and 6 pinpointed to a 120-kb region
 
of chromosome 14 susceptible to contain this 
putative minimal
 
region. A previously described breakpoint
15
 allowed us to narrow
 
down this 
region to 58kb lying more than 920-kb downstream of
 
BCL11B polyadenylation site. We used 
DNAse1 hypersensitive experiments
 
to identify active regulatory elements in this region. As 
shown
 
in Figure 1B, 5 HSSs were observed in T-ALL cell lines (DND41
 
and Jurkat), but were 
absent or weaker in the non–T-cell
 
lines Nalm6 and K562 (Figure S2).
 
 
 To investigate for cis-activating properties, 1.5-kb fragments
 
encompassing the HSSs 
were subcloned in pGL3-luciferase vector
 
and tested for activation of the SV40 promoter. 
Only 2 regions
 
(H3 and H4) showed enhancement of SV40 promoter activity in
 
HPB-ALL 
(Figure 2A). Fine mapping of the HSS and luciferase
 
reporter assays allowed us to map the 
active sequences within
 
464-bp (H3*) and 482-bp (H4*) fragments (data not shown and
 
Figure 2B). As expected, cis-activation was observed in T-cell
 
lines, but not in B-cell or 
myeloid cell lines. We next wanted
 
to ensure the activity of these sequences on the TLX3 
promoter.
 
A 504-bp fragment within the 5' side of TLX3 was subcloned in
 
promoter-less 
pGL3-luciferase vector (Figures S3 and S4). As
 
shown in Figure 2C, H3* and H4* sequences 
stimulated the TLX3
 
promoter, which exhibited only a weak activity on its own in
 
T-cell lines. 
Taken as a whole, our results identify T-lymphoid–restricted
 
(within the hematopoietic 
system) cis-activating elements downstream
 
of BCL11B that are juxtaposed to the TLX3 locus 
as a result
 
of the t(5;14).
 
 
 Our observations suggest that the recombinase activity is not
 
responsible for the 
occurrence of the t(5;14) in contrast with
 
the SIL-TAL1 deletion. They rather suggest that the 
reason for
 
the association between t(5;14) and T-ALL is the juxtaposition
 
of cis-
transcriptional regulatory elements that are specifically
 
active during T-cell differentiation. In 
keeping, murine Bcl11b
 
is very highly expressed at starting from DN2 (and latter) stage
 
of 
thymic development (data not shown).
 
 
 The t(5;14) situation is the most frequent example observed
 
in T-ALL that results in 
bona fide cis-activation due to enhancer
 
juxtaposition. The frequent SIL-TAL1 fusion leads to 
transcription
 
of TAL1 from the SIL promoter.
5
 The breakpoints of chromosomal
 
translocation 
affecting the TCR  locus frequently affect the
 
5' part of the oncogene on the partner 
chromosome, and result
 
in the transcription from diversity region or cryptic promoters
 
close to 
the translocation breakpoints.
18-21
 We provide here
 
only qualitative notions, and additional 
work will be necessary
 
to fully characterize the BCL11B gene cis-regulating elements.
22,23 
However, it is tempting to speculate that the activity of these
 
transcriptional regulatory regions 
represents a therapeutic
 
target in t(5;14) patients.
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Figure 1.. Structural analyses of the loci involved in t(5;14) identify putative 
transcriptional cis-regulatory elements. (A) Localization of the translocation breakpoints 
on chromosome 5 (top) and on chromosome 14 (bottom). Vertical arrows indicate the location 
of the breakpoints. The number refers to the patient's number. The majority of chromosome 5 
breakpoints is located in a 69-kb area between exons 20 to 25 (shown by vertical lines) of 
RANBP17. A horizontal arrow indicates the sense of transcription of the genes. The 
chromosome 14 breakpoints are spread over 842 kb downstream of BCL11B, in a region 
devoid of any obvious gene.
7,14
 The nucleotide sequences of the breakpoints are presented in 
Figure S1. Note that the breakpoint of patient 1 is located in the 3' untranslated region of 
TLX3. The chromosome 14 region that is juxtaposed in cis to the TLX3 gene in every t(5;14) 
patient characterized here is located between the breakpoints of patients 1 and 6. F1 indicates 
the breakpoint of a complex t(7;14;15) reported previously
15
 that allows the breakpoint to 
narrow the "critical" region to a 58-kb area indicated by a black rectangle. (B) DNAse1 
mapping experiments in the chromosome-14 region predicted to contain transcriptional 
regulatory elements. (Top) Map of the 58-kb chromosome-14 area analyzed in this 
experiment, showing EcoRV (EV) and BamHI (BHI) sites and the probes used. The numbers 
refer to chromosome 14 genomic sequences (NCBI Build36; NCBI, Bethesda, MD). (Bottom) 
Southern blot analysis of DNAse1 hypersensitivity experiments using DND41 cells. 
Increasing concentrations of DNAse1 reveal 5 hypersensitive sites (the corresponding 
fragments are shown by arrows). The sizes of the germ-line fragments are indicated. 
Additional experiments are presented in Figure S2. 
                                
  
Figure 2.. Identification of cis-regulator elements active on the TLX promoter active in 
T-cell lines. (A) Transcriptional regulatory activity of HSSs 1 to 5. Fragments encompassing 
the HSSs were subcloned in pGL3 (S-pGL3: containing an SV40 promoter) and tested by 
transient transfection in HPB-ALL. Luciferase activities are in arbitrary units (AU) and not 
normalized. (B) Fragments from H3 and H4 were tested for transcriptional activity using S-
pGL3 luciferase reporter vector in HPB-ALL (T-ALL; left panel) and Nalm6 (BCP-ALL; 
right panel) cell lines. Three different concentrations of vector were used. Values are 
indicated as fold of activation with respect to 0.5 µg S-pGL3 vector independently in each cell 
line. Data were normalized using a -galactosidase reporter. (C) H3* and H4* are active 
on SV40 (left panel) and TLX3 (right panel) promoters. Normalized values are indicated as 
fold of activation with respect to 0.5 µg S-pGL3 vector (left panel) or 0.5 µg T-pGL3 (right 
panel). The nucleotide sequence of fragments H3* and H4* is shown in Figure S5. Error bars 
indicate standard deviations. 
 
